Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001776978 | SCV002014007 | uncertain significance | not provided | 2020-01-07 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004953065 | SCV005455250 | uncertain significance | Inborn genetic diseases | 2024-10-21 | criteria provided, single submitter | clinical testing | The c.6724C>G (p.P2242A) alteration is located in exon 43 (coding exon 43) of the NBEA gene. This alteration results from a C to G substitution at nucleotide position 6724, causing the proline (P) at amino acid position 2242 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |